Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Garin, Noeca
  • dc.contributor.author Velasco, Cesarca
  • dc.contributor.author Pourcq, Jan T. Deca
  • dc.contributor.author López, Belenca
  • dc.contributor.author Gutierrez, Maria del Marca
  • dc.contributor.author Haro Abad, Josep Mariaca
  • dc.contributor.author Feliu, Annaca
  • dc.contributor.author Mangues, Maria A.ca
  • dc.contributor.author Trilla, Antonica
  • dc.date.accessioned 2015-10-29T09:00:38Z
  • dc.date.available 2015-10-29T09:00:38Z
  • dc.date.issued 2015
  • dc.description.abstract BACKGROUND: Adherence problems, interactions and higher rate of risk activities have been observed in HIV individuals using recreational drugs. Our aim was to describe recreational drug use in both HIV individuals and general population in Europe, and to assess at what extent HIV guidelines address this issue. METHODS: Data on recreational drug use across Europe were obtained from the European Monitoring Centre for Drugs and Drug Addiction for the general population, and through Pubmed search. for HIV patients. We assessed the incorporation of recreational drug issues in HIV treatment guidelines for the following topics: (a) recreational drugs; (b) adherence to antiretrovirals; (c) interactions; (d) transmission risk. Guidelines included: World Health Organization; European Aids Clinical Society; U.S. Department of Health and Human Services; International Antiviral Society-USA; and seven European national guidelines. RESULTS: 29 countries reported recreational drug use in general population. The highest prevalences were observed for Cannabis (i.e., 8-10% in Spain, France, and Czech Republic) followed by cocaine, amphetamines and ecstasy. The 13 studies selected in the systematic review showed a great variability in recreational drug use on the HIV population. Apart from classical recreational drugs, we found a relevant use of new drugs including sexual experience enhancers. Polydrug consumption was about 50% in some studies. Most guidelines included general information about recreational drugs, showing great variability on the inclusion of the evaluated topics. We found more specific, evidence-based recommendations on interactions, followed by medication adherence and transmission risk. CONCLUSIONS: Available data on the people living with HIV suggest a higher use of recreational drugs than in the general population, which is already relevant. However, recreational drug issues should be included or addressed more thoroughly in most guidelines.ca
  • dc.format.mimetype application/pdfca
  • dc.identifier.citation Garin N, Velasco C, Pourcq JT de, Lopez B, Gutierrez M del M, Haro JM. et al. Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations. Front Microbiol. 2015 Jul 14;6:690. doi: 10.3389/fmicb.2015.00690.ca
  • dc.identifier.doi http://dx.doi.org/10.3389/fmicb.2015.00690
  • dc.identifier.issn 1664-302X
  • dc.identifier.uri http://hdl.handle.net/10230/24952
  • dc.language.iso engca
  • dc.publisher Frontiersca
  • dc.relation.ispartof Frontiers in Microbiology. 2015 Jul 14;6:690
  • dc.rights Copyright © 2015 Garin, Velasco, De Pourcq, Lopez, Gutierrez, Haro, Feliu, Mangues and Trilla. This is an open-access article distributed under the terms of the http://creativecommons.org/licenses/by/4.0/ (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.ca
  • dc.rights.accessRights info:eu-repo/semantics/openAccessca
  • dc.rights.uri http://creativecommons.org/licenses/by/4.0/ca
  • dc.subject.other VIH (Virus) -- Tractamentca
  • dc.title Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.ca
  • dc.type info:eu-repo/semantics/articleca
  • dc.type.version info:eu-repo/semantics/publishedVersionca

Col·leccions

Articles (Hospital del Mar Research Institute)